Neogen Corporation (NEOG) Earnings Call Transcripts

Neogen Corporation's Latest Earnings Call - Q3 FY2026

In the third quarter of fiscal year 2026, Neogen Corporation (NEOG:US) reported revenues of $211.2 million, reflecting a slight 0.1% increase on a core basis. The Food Safety segment showed resilience with $156.7 million in revenue, achieving 4% core growth, while the Animal Safety segment faced challenges, declining 8.7% due to supply chain disruptions. Management raised full-year revenue guidance to $857 million to $860 million, indicating stronger-than-expected performance, but maintained adjusted EBITDA guidance at $175 million amidst ongoing supply chain issues.

Reported metrics

Guidance from management

Management raised full-year revenue guidance to $857 million to $860 million but maintained adjusted EBITDA guidance at $175 million, citing ongoing supply chain challenges.

What management said

Yes. Thanks, Subbu. Yes, I think we talked about a little bit on the call some of the issues that we had in sample collection during the quarter. We made -- some of those have resolved themselves. I would not expect it to step up from where we're at, and I would expect it to improve sequentially as we get to the fourth quarter.

Yes, surprised, no. That's I hope -- it's November 2026. We're on track. Maybe what we were trying to say is that in addition to that, we continue our 3M agreement until August of 2027 as an "insurance policy" for any disruption we may have.

What analysts pressed on

Analysts expressed concerns regarding the sustainability of growth in the Animal Safety segment and the impact of supply chain disruptions. There were questions about the company's ability to manage costs effectively amidst rising freight and transportation expenses.

Main topics on the call

• Revenue Growth in Food Safety — Neogen's Food Safety segment achieved $156.7 million in revenue, marking a 4% core growth, consistent with market dynamics. CEO Mike Nassif stated, "We delivered solid core growth in our Food Safety segment again this qu...
• Challenges in Animal Safety — The Animal Safety segment reported a revenue decline of 8.7% due to supplier disruptions. Nassif noted, "The issues stem primarily from disruptions at our third-party suppliers that related to product documentation, raw ...
• Adjusted EBITDA Improvement — Adjusted EBITDA increased to $48.2 million with a margin of 22.8%, reflecting strong cost control despite lower revenue. CFO Bryan Riggsbee highlighted, "Adjusted operating expenses were down 9% from second quarter level...
• Guidance Update — Management raised full-year revenue guidance to $857 million to $860 million, citing stronger-than-expected third-quarter results. However, they maintained adjusted EBITDA guidance at $175 million due to ongoing supply c...

Read the full Neogen Corporation transcript (Q3 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 33 Neogen Corporation earnings call transcripts on record, spanning March 24, 2020 to July 30, 2026. Based on this history, Neogen Corporation reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

NEOG

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

33

First call

March 24, 2020

Most recent

July 30, 2026

Reporting cadence

quarterly